Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Ketamine + midazolam) by Melt Pharmaceuticals for Sedation: Likelihood of Approval
(Ketamine + midazolam) is under clinical development by Melt Pharmaceuticals and currently in Phase III for Sedation. According to GlobalData,...